Skip to Content

Join the 'Hepatitis B' group to help and get support from people like you.

Hepatitis B News

Related terms: Chronic Hepatitis B, Hepatitis B, Chronic, HBV

Use of Needle Exchange Programs Up Dramatically in 10 Years: CDC

Posted 5 days ago by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Although there was a significant increase in the use of syringe services programs (SSPs) – more commonly known as needle exchange programs – across the United States over the past decade, many injection drug users don't always use sterile needles, a federal government report says. Previously used needles put drug users at risk for infectious diseases such as HIV and hepatitis B and C, the report noted. Needle exchange programs provide sterile needles and syringes to injection drug users. These programs also refer drug users to prevention, care and treatment services. Researchers from the U.S. Centers for Disease Control and Prevention looked at data from injection drug users in 22 cities with high rates of HIV. In 2015, 54 percent of injection drug users said they used a needle exchange program in the past year. That was up significantly compared to the 36 ... Read more

Related support groups: Opiate Dependence, Hepatitis C, HIV Infection, Drug Dependence, Hepatitis B, Pre-Exposure Prophylaxis, Substance Abuse, Toxic Reactions Incl Drug and Substance Abuse, Hepatitis B Prevention, Exposure to Hepatitis B Virus, Hepatitis B Prophylaxis

FDA Approves Gilead’s Vemlidy (tenofovir alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Posted 15 Nov 2016 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 10, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label regarding the risks of lactic acidosis/severe hepatomegaly with steatosis and post-treatment severe acute exacerbation of hepatitis B. See below for important safety information. Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to and at a dose less than one-tenth that of Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300mg. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it ca ... Read more

Related support groups: Hepatitis B, Viread, Tenofovir, Vemlidy, Tenofovir Alafenamide

Robotic Surgical Tools Tough to Keep Clean

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Even with repeated cleanings, it's virtually impossible to remove all contamination from robotic surgical instruments, a new study suggests. "One of the top priorities for hospitals is to treat patients safely and with minimal risk of infection," said study author Yuhei Saito, an assistant professor at the University of Tokyo Hospital in Japan. "Our results show that surgical instruments could be placing patients at risk due to current cleaning procedures. One way to address this issue is to establish new standards for cleaning surgical instruments, including multi-part robotic tools," Saito said in a news release from the Society for Healthcare Epidemiology of America. Over the course of 21 months, the researchers assessed protein residue on 132 robotic and standard surgical instruments that were cleaned according to manufacturers' instructions. The cleanings ... Read more

Related support groups: Infections, Surgery, Bacterial Infection, Hepatitis C, Hepatitis B, Hepatitis A, Surgical Prophylaxis, Gastrointestinal Surgery, Cardiothoracic Surgery

FDA Medwatch Alert: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating

Posted 10 Oct 2016 by Drugs.com

ISSUE: The FDA is warning about the risk of hepatitis B virus (HBV) becoming an active infection again in any patient who has a current or previous infection with HBV and is treated with certain direct-acting antiviral (DAA) medicines for hepatitis C virus. In a few cases, HBV reactivation in patients treated with DAA medicines resulted in serious liver problems or death. HBV reactivation usually occurred within 4-8 weeks. As a result, FDA is requiring a Boxed Warning, our most prominent warning, about the risk of HBV reactivation to be added to the drug labels of these DAAs directing health care professionals to screen and monitor for HBV in all patients receiving DAA treatment. This warning will also be included in the patient information leaflet or Medication Guides for these medicines. BACKGROUND: Direct-acting antiviral medicines are used to treat chronic hepatitis C virus (HCV) ... Read more

Related support groups: Hepatitis C, Harvoni, Hepatitis B, Sovaldi, Sofosbuvir, Zepatier, Epclusa, Viekira Pak, Daklinza, Ledipasvir/sofosbuvir, Olysio, Ombitasvir/paritaprevir/ritonavir, Viekira XR, Simeprevir, Daclatasvir, Technivie, Elbasvir/grazoprevir, Dasabuvir/ombitasvir/paritaprevir/ritonavir, Sofosbuvir/velpatasvir

Tips for Avoiding Back-to-School Germs, Illnesses

Posted 23 Sep 2016 by Drugs.com

FRIDAY, Sept. 23, 2016 – Kids and germs seem to go together like peanut butter and jelly. But, there are ways that parents can help protect their kids from the usual barrage of back-to-school illnesses, a health expert says. Make sure children get plenty of sleep and eat a well balanced diet, advises Jacqueline Stout-Aguilar. She's a registered nurse and an assistant professor at the Texas A&M College of Nursing. Most kids need at least nine hours of sleep each night, Stout-Aguilar said. It's also a good idea to make sure children get enough vitamin C to boost their immune system, she added. Parents should also teach their children how to contain germs and keep their hands clean. Show kids how to cover their coughs and sneezes with the inside of their elbow or a tissue, Stout-Aguilar said. She said kids must also be taught how to wash their hands properly. "It is important to wash your ... Read more

Related support groups: Influenza, Hepatitis B, Pre-Exposure Prophylaxis, Hepatitis A, Measles, Tetanus Toxoid, Rubella, FluLaval, Varicella Virus Vaccine, Pneumovax 23, Pneumococcal 23-polyvalent Vaccine, Afluria, Measles Virus Vaccine, FluMist, Kinrix, Fluzone, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Mumps Virus Vaccine, Rubella Virus Vaccine, Mumps Virus Vaccine/Rubella Virus Vaccine

Serious Infections Tied to Suicide Risk

Posted 10 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 10, 2016 – People hospitalized for serious infections may face an increased risk of dying by suicide, and researchers suspect there's a biological reason for it. In a study of over 7 million people, Danish researchers found that those who'd been hospitalized for infections were 42 percent more likely to die of suicide compared to people with no history of serious infection. People hospitalized for HIV/AIDS or the liver infection hepatitis showed the highest risk – more than twice that of people without those diseases, the study found. Although the study couldn't prove a cause-and-effect link, the study authors and at least one other brain health expert think the increased risk of suicide after infection might not simply reflect the psychological impact of serious illness. Instead, infections might directly contribute to suicide risk by causing inflammation in the ... Read more

Related support groups: Depression, Major Depressive Disorder, Hepatitis C, HIV Infection, Postpartum Depression, Hepatitis B, Dysthymia, Seasonal Affective Disorder, Hepatitis A, Neurotic Depression, Depressive Psychosis, Chronic Active Hepatitis, Infectious Hepatitis

Ridding U.S. of Hepatitis B, C as 'Public Health Problem' Possible: Experts

Posted 11 Apr 2016 by Drugs.com

MONDAY, April 11, 2016 – Experts say there's real hope in someday ridding the United States of the "public health problem" of hepatitis B and C infection. The two viral strains cause serious, often fatal, liver disease for tens of thousands of Americans each year. The comprehensive new report is from a panel of experts at the U.S. National Academies of Sciences, Engineering, and Medicine. They believe that the advent of a powerful new vaccine and medicines could help drastically lower hepatitis B and C rates across the country. Still, to reach that goal will take time and considerable resources, the report said. "Ending illness and deaths from hepatitis C depends on both stopping the disease's progression in its early stages and reversing the course of advanced disease," the committee said in a news release. According to the report, between 700,000 and 1.4 million Americans have ... Read more

Related support groups: Hepatitis C, Cirrhosis, Hepatitis B, Liver Cirrhosis, Exposure to Hepatitis B Virus, Hepatic Tumor

U.S. Cancer Death Rate Continues to Fall

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – Overall rates of cancer and deaths from cancer in the United States continue to decline, a newly released report says. However, an increase in liver cancer deaths is cause for concern, the report authors noted. An increase in hepatitis C infections is likely a major reason for the increase, they said. "The latest data show many cancer prevention programs are working and saving lives," Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said in a news release from the organizations that issued the report. "But the growing burden of liver cancer is troublesome. We need to do more work promoting hepatitis testing, treatment, and vaccination," Frieden added. The Report to the Nation on the Status of Cancer is released each year by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the National Cancer ... Read more

Related support groups: Cancer, Hepatitis C, Smoking, Breast Cancer, Prostate Cancer, Smoking Cessation, Cirrhosis, Lung Cancer, Colorectal Cancer, Basal Cell Carcinoma, Hepatitis B, Liver Cirrhosis, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer

Assessing Health Issues of Child Refugees

Posted 29 Nov 2015 by Drugs.com

FRIDAY, Nov. 27, 2015 – The main health problems of refugee children from Asia and Africa when they arrive in the United States are outlined in a new study. Based on screenings of more than 8,100 young refugees between 2006 and 2012, the top health concerns were hepatitis B, tuberculosis, parasitic worms, high blood lead levels and anemia, the study found. The refugees, all younger than 19, were from Bhutan, Myanmar, the Democratic Republic of the Congo, Ethiopia, Iraq and Somalia. The screenings were conducted shortly after they arrived in Colorado, Minnesota, Pennsylvania and Washington state. In general, these conditions were more common among children from the Democratic Republic of the Congo, Ethiopia and Somalia, and lower among those from Iraq, researchers said. Among refugees from Myanmar, those who came to the United States from Thailand had more diseases than those who came ... Read more

Related support groups: Anemia, Hepatitis B, Tuberculosis - Latent, Tuberculosis - Active, Lead Poisoning, Helminthic Infection, Worms and Flukes

HIV Therapy May Also Lower Risk for Hepatitis B, Study Says

Posted 12 Oct 2015 by Drugs.com

MONDAY, Oct. 12, 2015 – Not only does effective HIV therapy thwart the AIDS-causing virus, it may also reduce the risk for hepatitis B infection, a new study says. "What this means to us is that effective HIV therapy appears to restore an impairment in the immune response that protects someone with HIV from acquiring hepatitis B infection," study senior author Dr. Chloe Thio, a professor of medicine at Johns Hopkins University School of Medicine, said in a university news release. The study, published in the October issue of Annals of Internal Medicine, involved 2,400 gay and bisexual men who were enrolled in the Multicenter AIDS Cohort Study. Researchers found that the men successfully treated with HIV therapy had the same risk for hepatitis B infection as the men who did not have HIV. Hepatitis B is a virus that can damage the liver. The study showed HIV-positive men on HIV therapy ... Read more

Related support groups: Harvoni, HIV Infection, Valtrex, Acyclovir, Hepatitis B, Atripla, Ribavirin, Sovaldi, Valacyclovir, Pre-Exposure Prophylaxis, Incivek, Zovirax, Truvada, Pegasys, Stribild, Triumeq, Complera, Baraclude, Victrelis, Famciclovir

Task Force Recommends Hep B Screening for High-Risk People

Posted 27 May 2014 by Drugs.com

MONDAY, May 26, 2014 – Doctors should regularly screen people at high risk for contracting the hepatitis B virus, which causes chronic illness and can lead to liver cancer if left untreated, a national panel of health experts has recommended. The U.S. Preventive Services Task Force advised that specific groups of people should undergo screening for hepatitis B, including: People born in countries with a high rate of infection, mainly in Asia, sub-Saharan Africa, the Pacific Islands, the Middle East and Eastern Europe. Those who share risk factors similar to those for HIV, including injection drug users, men who have sex with men, and people living with or having sex with someone with a hepatitis B infection. Patients with a weakened immune system or who are undergoing treatment for kidney failure. There is no cure for hepatitis B. But a vaccine now exists and antiviral treatments ... Read more

Related support groups: Hepatitis B

FDA Medwatch Alert: Recombivax HB (Hepatitis B Vaccine (Recombinant)) Adult Formulation by Merck Sharp and Dohme Corp.: Recall - Potential For Cracked Vials

Posted 4 Jul 2013 by Drugs.com

ISSUE: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (Merck), initiated this voluntary recall due to the potential for a limited number of cracked vials to be present in the lot. Merck’s investigation concluded that for certain vials in the affected lot, the potential exists for a crack to have occurred in the vial. If the vial was cracked, the integrity of the vial and the sterility of any product remaining in the vial could not be assured. BACKGROUND:  Lot Number J001183 of Recombivax HB Adult Formulation is the only lot impacted by the recall and was distributed solely within the United States. The lot was distributed by Merck between March 12, 2013 and May 2, 2013. There is adequate inventory to replace recalled product at this time. RECOMMENDATION: If product from this lot has been administered, revaccination is not necessary. Customers are asked to inventory and qua ... Read more

Related support groups: Hepatitis B, Recombivax HB Adult, Recombivax HB

Vaccines Might Become Another Way to Fight Cancer

Posted 18 Jan 2013 by Drugs.com

FRIDAY, Jan. 18 – Most people think of the flu when the word "vaccine" comes up in conversation, but several vaccines also exist to help prevent cancers. Not only that, numerous researchers are also working to harness the power of the body's immune system to develop vaccines to help treat cancer. "Essentially, cancer treatment vaccines are the ultimate in personalized medicine," said Dr. Linda Liau, director of the brain tumor program at the University of California, Los Angeles. Liau is currently researching a brain cancer treatment vaccine. Dr. Jeffrey Hardacre, who's researching a pancreatic cancer vaccine, agreed. "This is an area that remains in its infancy, and I think we only have brighter things to look forward to," he said. "Using the body's immune system is a potent way to fight cancers." Hardacre is an associate professor of surgery and head of the pancreatic surgery section ... Read more

Related support groups: Hepatitis B, Pancreatic Cancer, Condylomata Acuminata, Gardasil, Hepatitis B Adult Vaccine, Twinrix, Cervarix, Provenge, Human Papillomavirus Vaccine, Sipuleucel-t, Engerix-B, Hepatitis A Adult Vaccine/hepatitis B Adult Vaccine

Hepatitis: The Hidden Hazard

Posted 21 Dec 2012 by Drugs.com

FRIDAY, Dec. 21 – Of all the diseases people worry about getting, viral hepatitis is usually way down on the list. Most often it's thought of as a disease that affects only drug addicts or the sexually promiscuous. Though those groups are at higher risk, almost anyone can contract hepatitis. "The vast majority of people who have viral hepatitis, especially hepatitis C, don't know they have it, and that's the biggest problem we have with hepatitis," said Dr. David Bernstein, chief of hepatology at North Shore University Hospital in Manhasset, N.Y. A bipartisan bill was introduced in Congress last year, the Viral Hepatitis Testing Act of 2011, that would establish a national system to identify the incidence of hepatitis B and C infections, and provide funding to increase the availability of testing. According to the Centers for Disease Control and Prevention (CDC), more than 2 million ... Read more

Related support groups: Hepatitis C, Hepatitis B, Hepatitis A

Antiviral Therapy May Cut Recurrence of Hepatitis B-Linked Liver Cancer

Posted 12 Nov 2012 by Drugs.com

MONDAY, Nov. 12 – People with liver cancer tied to infection with the hepatitis B virus who got antiviral therapy after cancer surgery had a lower risk of tumor recurrence than those who did not get it, according to a new study. "Hepatitis B infection commonly leads to the development of liver cancer in patients with and without cirrhosis," explained one expert not connected to the study, Dr. David Bernstein, chief of the division of hepatology at North Shore University Hospital in Manhasset, N.Y. He also noted that antiviral therapy is now standard practice for these patients. Most experts "agree that all patients with hepatitis B and liver cancer, whether cirrhosis is present or not, and any level of the hepatitis B virus in the blood should be treated with antiviral therapy," Bernstein said. In the new study, Taiwanese researchers compared results for more than 4,500 patients who ... Read more

Related support groups: Hepatitis B, Baraclude, Viread, Entecavir, Tenofovir, Lamivudine, Abacavir, Epivir, Hepsera, Didanosine, Zidovudine, Stavudine, Adefovir, Ziagen, Retrovir, Telbivudine, Videx, Zalcitabine, Emtriva, Epivir-HBV

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Exposure to Hepatitis B Virus, Infectious Hepatitis

Related Drug Support Groups

Pegasys, Baraclude, PegIntron, Viread, tenofovir, entecavir, interferon alfa-2b, lamivudine, Epivir, view more... Hepsera, Intron A, peginterferon alfa-2b, peginterferon alfa-2a, Vemlidy, telbivudine, adefovir, Tyzeka, Epivir-HBV, tenofovir alafenamide